Liquid biopsies use blood samples to identify DNA biomarkers from tumor cells circulating in the blood for the early detection of cancer.

By combining our liquid biopsy technology with our proprietary cell-based diagnostics, NKore can measure the patient’s innate immune system at a cellular level, including the patient’s NK cell function, to provide treating physicians with the tools they need to develop better personalized treatment plans for their patients....true personalized medicine.

Dr. Jewett’s IP portfolio includes patents to develop a robust diagnostic platform measuring cellular function that is not limited to use with super charged NK therapies. 

NKore is on a path to make these tests widely available to the public at large so individuals will have the ability to understand when their immune function has been compromised and, with the benefit of that information, evaluate treatment options earlier in the progression of the disease.

If early detection is the key to effective treatment, understanding your body’s NK function is the key to early detection.

The NK Cell diagnostic suite of tests are for research use only. Not for use in diagnostic procedures.

Suite of Tests

(AVAILABILITY TBD)

NK Cell Test / tumor Killing assay

NK Cell death

NK proliferation

NK expansion with monocytes

Cytokine Release

Surface Analysis / 1 Expressions